Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.46 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.46 |
| ▸ | BRD4 | O60885 | 3/20 | 0.42 |
| ▸ | SYK | P43405 | 2/20 | 0.40 |
| ▸ | CAMK1D | Q8IU85 | 2/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 4/20 | 0.39 |
| ▸ | TNNI3K | Q59H18 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | BRAF | P15056 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | TYK2 | P29597 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30069228 | 0.84 | BCL6 (0.45) | SYKKDREGFRLMNAKDM4E | |
| SCHEMBL30069223 | 0.80 | SYK (0.51) | ABCG2GRM4BRD4SYKKDR | |
| SCHEMBL18757495 | 0.73 | BRAF (0.44) | ABCG2GRM4BRD4SYKCAMK1D | |
| SCHEMBL12279158 | 0.72 | BRD4 (0.56) | ABCG2GRM4BRD4SYKCAMK1D | |
| SCHEMBL24754871 | 0.72 | MAPT (0.49) | ABCG2GRM4SYKEGFRBRAF | |
| SCHEMBL30069230 | 0.72 | SYK (0.41) | ABCG2GRM4BRD4SYKEGFR | |
| SCHEMBL21625856 | 0.72 | KIF11 (0.54) | ABCG2GRM4EGFRTNNI3KHRH3 | |
| SCHEMBL29514710 | 0.72 | KIF11 (0.54) | ABCG2GRM4EGFRTNNI3KHRH3 | |
| SCHEMBL12266446 | 0.71 | MAPT (0.53) | ABCG2GRM4BRD4KDREGFR | |
| SCHEMBL17526197 | 0.71 | BRD4 (0.58) | ABCG2GRM4BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12610730-B2 | Metal complex and light emitting device | CITY UNIVERSITY OF HONG KONG (HK) | 2026-04-21 | — | — | US | disclosed |
| US-20230006152-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE | CITY UNIVERSITY OF HONG KONG (HK) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230006152-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE | OCIAD1, OCIAD2, OPRD1 | ABCG2 2953/4885GRM4 2352/4885BRD4 448/4885 |
| US-12610730-B2 | Metal complex and light emitting device | OPRD1, OCIAD2, ORC3 | ABCG2 2555/4885GRM4 999/4885BRD4 212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.